Bloomberg: Intrivo CEO on CareStart™ EUA approvals

Bloomberg: Intrivo CEO on CareStart™ EUA approvals

Bloomberg: Intrivo CEO on CareStart™ EUA approvals 1920 1280 CareStart™

Reeve Benaron, chairman and interim chief executive officer at Intrivo, discusses the U.S. Food and Drug Administration’s emergency use authorization of a Covid-19 antigen test the company distributes for Access Bio. Benaron speaks with Bloomberg’s Emily Chang. (Source: Bloomberg)